Will Biomarkers Succeed as a Surrogate Endpoint in Heart Failure Trials?

被引：9
|
作者：
Januzzi, James L., Jr. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Cardiol Div, 32 Fruit St,Yawkey 5984, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA USA
来源：
JACC-HEART FAILURE | 2018年 / 6卷 / 07期
关键词：
biomarker; heart failure; outcomes;
D O I：
10.1016/j.jchf.2018.02.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：570 / 572
页数：3
相关论文
共 50 条
  • [1] Biomarkers as Surrogate End Points in Heart Failure Trials
    Felker, G. Michael
    HEART FAILURE CLINICS, 2011, 7 (04) : 501 - +
  • [2] Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials
    Follen, M
    Schottenfeld, D
    CANCER, 2001, 91 (09) : 1758 - 1776
  • [3] Surrogate endpoint biomarkers for cervical cancer chemoprevention trials
    Ruffin, MT
    Ogaily, MS
    Johnston, CM
    Gregoire, L
    Lancaster, WD
    Brenner, DE
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 113 - 124
  • [4] Validation of surrogate endpoint biomarkers in prostate cancer chemoprevention trials
    Trock, BJ
    UROLOGY, 2001, 57 (4A) : 241 - 247
  • [5] Ventricular remodeling in heart failure: A credible surrogate endpoint
    Konstam, MA
    Udelson, JE
    Anand, IS
    Cohn, JN
    JOURNAL OF CARDIAC FAILURE, 2003, 9 (05) : 350 - 353
  • [6] Surrogate end points in heart failure trials
    Gheorghiade, M
    Adams, KF
    Gattis, WA
    Teerlink, JR
    Orlandi, C
    O'Connor, CM
    AMERICAN HEART JOURNAL, 2003, 145 (02) : S67 - S70
  • [7] Beyond dyspnoea as an endpoint in acute heart failure trials
    Gheorghiade, Mihai
    Ruschitzka, Frank
    EUROPEAN HEART JOURNAL, 2011, 32 (12) : 1442 - 1445
  • [8] Microalbuminuria as Surrogate Endpoint in Therapeutic Trials
    Josep Redon
    Fernando Martinez
    Current Hypertension Reports, 2012, 14 : 345 - 349
  • [9] Microalbuminuria as Surrogate Endpoint in Therapeutic Trials
    Redon, Josep
    Martinez, Fernando
    CURRENT HYPERTENSION REPORTS, 2012, 14 (04) : 345 - 349
  • [10] Surrogate endpoint biomarkers in chemopreventive agent development
    Lippman, SM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S67 - S67
12345